Lily awards £178,000 of new funding for mito research

24 May 2022

The Lily Foundation has increased its research funding with grants for two exciting new projects that could improve the lives of people with mitochondrial disease. 

The two studies are the successful applicants of the charity's 2021/22 funding call, which awards grants to the most promising evidence-based mitochondrial research proposals. 

The new projects include: a study at Newcastle University to test the efficacy of using remote microphones (assisted listening devices) to help adult mitochondrial patients affected by hearing loss; and a study at UCL to test a groundbreaking Deoxynucleoside treatment using mouse models of mitochondrial disease.

The studies are both based in the UK and led by leading experts in the field of mitochondrial disease. 

Thanks to the generous donations and incredible fundraising efforts of Lily families and supporters, the charity has been able to award a total of £178,000 of research funding this year. 

All Lily funding applicants are subject to a rigorous peer review process, and all research must also be approved by the Health Research Authority (HRA). 

The Lily Foundation is proud to be the largest charitable funder of mitochondrial research in Europe. To date, the charity has invested over £2.8 million into researching potential treatments or a cure for mitochondrial disease.  

To find out more about the latest research projects funded by The Lily Foundation visit our Lily Research webpage. You can also read our recent interview with Antonella Spinazzola, the neurologist behind the UCL project. 

Please help fund our research

The Lily Foundation is committed to finding effective treatments, and eventually a cure, for mitochondrial disease, but we can only do this with your help.

Please donate today to help bring positive change to the lives of patients and their families.